Iovance Biotherapeutics, Inc.
H‑1B Sponsor Verified
Yes. Iovance Biotherapeutics, Inc. filed 42 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2020–2026, including 1 so far in 2026. The average H-1B salary is $174,657 and the most sponsored role is Associate Director, Statistical Programming.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Apr 30, 2026.
LinkedIn ↗Latest Year Filings
1
In 2026
↗ Filter by year
Total H‑1B Filings
42
Since 2020
↗ View records
Avg Annual Salary
$174,657
All years combined
↗ View chart
Top Role
Associate Director, Statistical Pr…
↗ Click to filter
Filing trend
H‑1B filings by year for Iovance Biotherapeutics, Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 1 | $257,566 |
| 2025 | 11 | $157,652 |
| 2024 | 11 | $183,876 |
| 2023 | 5 | $202,445 |
| 2022 | 8 | $177,375 |
| 2021 | 4 | $148,750 |
| 2020 | 2 | $147,500 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary